A prescription-strength vitamin A derivative and the gold standard retinoid in dermatology — the most clinically studied topical anti-aging ingredient available.

Tretinoin binds to retinoic acid receptors in the dermis to directly stimulate collagen synthesis and accelerate epidermal cell turnover. It clears dead cells from the surface to reduce fine lines, uneven texture, and dullness — while the new cells produced beneath are structurally denser and more hydrated. It also normalizes melanocyte activity to fade hyperpigmentation and sun damage. Most premium formulas include it as the core anti-aging driver.

The mildest and safest naturally occurring estrogen, applied topically to restore estrogen-driven collagen, hydration, and skin structure lost with age.

Estrogen receptors in the dermis directly regulate procollagen synthesis, hyaluronic acid production, and sebaceous gland activity. After menopause or with hormonal decline, these receptors become understimulated and skin becomes thin, dry, and crepey. Topical estriol restores estrogenic signaling locally — improving elasticity, increasing dermal thickness, and locking in moisture — without significant systemic absorption. It also counteracts the collagen-degrading effects of cortisol and UV damage.

A naturally occurring copper-binding tripeptide that modulates over 4,000 human genes involved in skin repair, collagen synthesis, and cellular regeneration.

GHK-Cu activates fibroblasts to upregulate collagen, elastin, and glycosaminoglycan production — the three structural proteins that give skin firmness, bounce, and moisture retention. It simultaneously downregulates inflammatory and matrix-degrading pathways, suppresses fibrinogen synthesis (associated with scarring), promotes angiogenesis in repairing tissue, and activates the ubiquitin-proteasome system to clear damaged cellular proteins. It resets aging skin gene expression toward a younger phenotype.

A 5-alpha reductase inhibitor applied topically to the face to block DHT at sebaceous glands and facial hair follicles — without systemic hormonal effects.

DHT over-stimulates sebaceous glands and facial hair follicles, causing enlarged pores, excess sebum, and coarser facial hair — hallmarks of androgenic skin aging. Topical finasteride blocks DHT locally at the face without systemic absorption, shrinking pore size, reducing oiliness, and decreasing unwanted terminal facial hair. When combined with estriol and tretinoin, it provides a three-pronged approach to androgenic, hormonal, and structural skin aging simultaneously.

A synthetic lysine derivative originally used to control bleeding, now recognized as one of the most effective prescription brightening agents for hyperpigmentation and melasma.

Tranexamic acid interrupts the keratinocyte-to-melanocyte signaling pathway that triggers excess melanin production — blocking pigmentation at its source rather than just at the melanocyte level. It inhibits plasmin-mediated prostaglandin release, which is the upstream signal that instructs melanocytes to produce more melanin in response to UV exposure or inflammation. It addresses melasma, post-inflammatory hyperpigmentation, and sun spots at a mechanistic level unmatched by OTC brighteners.

The gold-standard prescription depigmenting agent — the most potent and clinically validated topical inhibitor of melanin synthesis available.

Hydroquinone is a phenolic compound that competitively inhibits tyrosinase — the rate-limiting enzyme in melanin biosynthesis — while simultaneously disrupting melanosome formation and accelerating the degradation of existing melanin in keratinocytes. At prescription concentrations (4%), it is significantly more potent than OTC preparations and produces measurable depigmentation of melasma, solar lentigines, and post-inflammatory hyperpigmentation within weeks. It is paired with tretinoin (which accelerates turnover to shed pigmented cells) and corticosteroids (which suppress the inflammation that re-triggers pigmentation) for maximum efficacy.

A naturally occurring chelating agent produced by fungi during fermentation — with established depigmenting activity through copper-dependent tyrosinase inhibition.

Kojic acid inhibits tyrosinase by chelating the copper ions in its active site — copper is essential for the enzyme's catalytic function, and without it, the conversion of tyrosine to melanin cannot proceed. Unlike hydroquinone, kojic acid achieves depigmentation without direct cytotoxic effects on melanocytes, making it well-suited for extended use and sensitive skin types. It is effective against solar lentigines, melasma, and post-inflammatory hyperpigmentation. Combined with hydroquinone, the two agents deliver synergistic depigmentation through complementary mechanisms — tyrosinase inhibition and copper chelation simultaneously.

A naturally occurring dicarboxylic acid derived from grains, with FDA-recognized efficacy for rosacea and hyperpigmentation in prescription concentrations (15–20%).

Azelaic acid selectively inhibits tyrosinase — the enzyme that catalyzes melanin synthesis — in abnormally active melanocytes, while leaving normal melanocytes unaffected. This makes it safe for all skin tones without risk of over-depigmentation. It also normalizes follicular cell turnover to prevent comedone formation, reduces the inflammatory lesions of rosacea and acne, and has mild antimicrobial activity against Cutibacterium acnes. One of the few ingredients that addresses pigmentation, redness, and acne simultaneously.

A water-soluble form of vitamin B3 with a uniquely broad mechanism of action — simultaneously addressing pigmentation, barrier integrity, inflammation, and retinoid tolerance.

Niacinamide inhibits the transfer of melanosomes (melanin-filled vesicles) from melanocytes to surrounding keratinocytes — reducing pigmentation without suppressing melanin production itself. It rebuilds the ceramide-rich skin barrier to reduce transepidermal water loss, suppresses the inflammatory cytokines driving post-inflammatory hyperpigmentation and rosacea, and dramatically reduces the irritation associated with tretinoin. In every formula it appears in, it serves as both an active and a stabilizer for the other ingredients.

The smallest alpha-hydroxy acid (AHA), derived from sugarcane, with deep skin penetration and the most clinically studied exfoliation profile of all chemical exfoliants.

Glycolic acid dissolves the ionic bonds holding dead corneocytes (skin cells) together at the surface, releasing them for easy shedding without physical abrasion. This chemical exfoliation reveals fresher, brighter skin below and significantly improves the penetration of other actives applied afterward. At deeper concentrations it also stimulates fibroblasts at the dermal-epidermal junction to produce new collagen — making it both a surface brightener and a structural remodeler. In the eye cream formula, it targets dark circles and skin texture around the delicate periorbital area.

The alcohol form of pantothenic acid (vitamin B5), which converts in the skin to pantothenic acid — a key cofactor in skin cell energy metabolism and wound healing.

Dexpanthenol penetrates deeply and converts to pantothenic acid in the skin, where it accelerates keratinocyte proliferation and migration to support wound healing and barrier recovery. It acts as a powerful humectant — attracting and binding water to the epidermis — while simultaneously stimulating fibroblast activity. In brightening formulas, it helps the skin repair itself from pigmentation-triggering micro-inflammation and supports even cellular renewal. It also significantly reduces the redness and peeling associated with prescription actives like tretinoin.

A naturally occurring glycosaminoglycan that holds up to 1,000 times its weight in water — the primary hydrating molecule in both the dermis and epidermis.

Hyaluronic acid draws water from the environment and deeper skin layers into the epidermis, creating visible plumping and reduction of surface fine lines within hours of application. At a structural level, it occupies the extracellular matrix between collagen and elastin fibers, maintaining the spacing and hydration that keeps the dermis resilient. When included in a formula with tretinoin and estriol, it anchors all actives in a hydrated environment that dramatically improves their bioavailability and tolerability, while directly reducing the dryness that retinoids commonly cause.

A polysaccharide-rich botanical extract with exceptional humectant, barrier-reinforcing, and anti-inflammatory properties — one of the most studied natural skin-calming agents.

The polysaccharides in aloe vera form a protective film over the skin surface that reduces transepidermal water loss while simultaneously delivering moisture into the epidermis. Its acemannan and glucomannan compounds support keratinocyte proliferation and barrier repair. In prescription formulas used for eczema and psoriasis, aloe vera provides essential barrier support and moisture delivery to the damaged skin tissue being treated by the corticosteroids — preventing over-drying and supporting the skin's recovery between flares.

A universal antioxidant that is both water- and fat-soluble — unlike most antioxidants — allowing it to protect cell membranes, cytoplasm, and the extracellular matrix simultaneously.

ALA neutralizes reactive oxygen species (free radicals) in both the aqueous and lipid compartments of skin cells — providing 360-degree antioxidant protection no single-phase antioxidant can match. It also regenerates other depleted antioxidants including vitamins C and E, extending the antioxidant network's overall effectiveness. It chelates iron to prevent iron-catalyzed oxidative damage, reduces glycation of collagen (sugar-mediated aging), and suppresses AP-1 — the transcription factor that activates matrix metalloproteinases (MMPs) that degrade collagen and elastin.

A water-soluble antioxidant and essential cofactor for collagen synthesis — the most abundant antioxidant naturally found in healthy skin.

Vitamin C is required for the hydroxylation of proline and lysine — the two reactions that stabilize the triple helix structure of collagen. Without adequate vitamin C, collagen produced is structurally weak and prone to degradation. It also directly scavenges free radicals generated by UV exposure and pollution, preventing the oxidative damage that drives collagen breakdown and hyperpigmentation. When combined with ALA, both antioxidants cross-protect each other, creating a sustained antioxidant defense in the skin.

Epigallocatechin gallate — the primary catechin polyphenol in green tea and one of the most potent naturally occurring antioxidants studied in dermatology.

EGCG scavenges reactive oxygen species generated by UV radiation, pollution, and metabolic activity — preventing oxidative damage to DNA, lipid membranes, and structural proteins in the dermis. It inhibits AP-1 and NF-κB — two transcription factors that activate matrix metalloproteinases (MMPs) which degrade collagen and elastin. EGCG also inhibits tyrosinase activity to reduce melanin production and has direct anti-inflammatory activity via COX-2 inhibition. In a depigmenting formula, it reinforces the brightening pathway while protecting newly revealed skin from the oxidative stress that re-triggers pigmentation.

A polyphenolic stilbene found in grape skins and berries — with potent antioxidant, anti-inflammatory, and SIRT1-activating properties studied extensively in aging and skin biology.

Resveratrol inhibits NF-κB signaling to suppress inflammatory cytokine production in the dermis, reducing the chronic low-grade inflammation that degrades collagen and drives pigmentation irregularities. It activates SIRT1 — a longevity deacetylase — which promotes DNA repair and counteracts the epigenetic changes associated with UV-induced photoaging. Topically, it scavenges free radicals, inhibits MMP-1 (collagenase), and reduces melanin synthesis via tyrosinase inhibition. In the Luminance formula, it protects the skin from re-oxidation while supporting the depigmenting actives alongside it.

A macrocyclic lactone antiparasitic agent FDA-approved for rosacea at 1% cream concentration — the only antiparasitic ingredient with a proven role in prescription skincare.

Demodex folliculorum mites — microscopic parasites that live in hair follicles and sebaceous glands — are found in significantly higher concentrations in rosacea-affected skin. Their waste products and death trigger inflammatory cascades that drive rosacea flares, papules, and pustules. Ivermectin eliminates Demodex mites by disrupting their glutamate-gated chloride channels, causing paralysis and death. Eliminating the mite burden removes a key inflammatory trigger and allows the skin's redness and reactivity to subside significantly.

A nitroimidazole antimicrobial and anti-inflammatory agent, FDA-approved for rosacea at prescription concentrations — one of the most prescribed topical rosacea treatments.

Metronidazole reduces the vascular inflammation, erythema (redness), and papulopustular lesions of rosacea through both antimicrobial and direct anti-inflammatory mechanisms. It generates reactive oxygen species metabolites that suppress the inflammatory cascade in the dermis and reduce vascular hyperreactivity. Combined with ivermectin and azelaic acid, it provides three-pathway control of rosacea: antimicrobial, antiparasitic, and anti-vascular inflammatory — addressing the condition from every angle.

A Class VII (lowest-potency) topical corticosteroid — the mildest glucocorticoid available, suitable for sensitive areas including the face, neck, and skin folds.

Hydrocortisone binds glucocorticoid receptors in dermal fibroblasts and keratinocytes to suppress prostaglandin, leukotriene, and pro-inflammatory cytokine synthesis — calming the vascular inflammation and erythema associated with rosacea, post-procedure irritation, and reactive skin. At low prescription concentrations, its safety profile allows facial use where mid- and high-potency steroids would cause atrophy. In the Luminance depigmenting formula, it suppresses the post-inflammatory melanogenesis triggered by UV exposure and inflammation — the cycle that perpetuates melasma — making it a strategic component of multi-mechanism brightening treatment.

A mid-potency fluorinated topical corticosteroid that suppresses a broad spectrum of inflammatory cytokines and vascular permeability signals.

Triamcinolone binds intracellular glucocorticoid receptors to suppress prostaglandin and leukotriene production, reducing both the inflammatory response and the vascular dilation that causes redness, swelling, and heat. In the puffy eye cream formula, it specifically targets the inflammatory component of periorbital puffiness — edematous swelling caused by vascular permeability and fluid accumulation around the orbital area. For eczema and psoriasis, it rapidly suppresses the immune overactivation driving epidermal hyperproliferation and barrier breakdown.

A Class I (super-potent) topical corticosteroid — the most potent class available — reserved for severe or treatment-resistant inflammatory skin conditions.

Clobetasol delivers the strongest topical anti-inflammatory effect available by prescription, suppressing the immune hyperactivation driving eczema, psoriasis, and lichen planus at the genomic level. It inhibits pro-inflammatory gene transcription, reduces epidermal hyperproliferation (the thickened, scaly plaques of psoriasis), and restores barrier function during flares. Used short-term alongside aloe vera in the Redness Reset formula, where its potency is balanced against the barrier-restoring and soothing properties of the aloe base to minimize thinning with chronic use.

A methylxanthine alkaloid that inhibits phosphodiesterase and adenosine receptors in blood vessel walls, producing localized vasoconstriction and reduced vascular permeability.

Applied to the periorbital area (under-eye), caffeine constricts the capillaries responsible for the dark, bluish hue of under-eye circles and reduces the vascular leakage that causes morning puffiness. It temporarily tightens the periorbital tissue for a visibly firmer, less swollen appearance. Caffeine also inhibits adipogenesis (fat cell formation) in facial tissue, which contributes to the deflation of eye bags over time with consistent use. When paired with tretinoin and glycolic acid, it provides both immediate vascular effects and longer-term structural improvement.

A lincosamide antibiotic that inhibits bacterial protein synthesis — the prescription topical antibiotic most commonly used for moderate-to-severe inflammatory acne.

Clindamycin targets Cutibacterium acnes — the anaerobic bacterium that colonizes sebaceous follicles and triggers the inflammatory cascade behind papules, pustules, and cysts. It binds the 50S ribosomal subunit to halt bacterial protein synthesis, reducing bacterial burden in the follicle and consequently suppressing the inflammatory response. Topical delivery concentrates it at the site of action in the follicle while minimizing systemic exposure. It is nearly always combined with benzoyl peroxide to prevent the development of antibiotic resistance.

An organic peroxide that releases free oxygen radicals in the follicle to kill acne bacteria — with no risk of antibiotic resistance, unlike clindamycin or other antibiotics used alone.

Benzoyl peroxide creates a highly oxidative environment inside the sebaceous follicle that is lethal to the anaerobic Cutibacterium acnes. Because it works through oxidative killing rather than a specific molecular target, resistance cannot develop — which is why it is prescribed alongside topical antibiotics like clindamycin. It also has mild comedolytic (pore-clearing) activity and reduces follicular hyperkeratinization. The combination of clindamycin and benzoyl peroxide produces outcomes superior to either agent alone while preventing resistance emergence.